Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 190 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

 		Pulmonary Arterial Hypertension Phase 2 Netherlands
Argentina
Germany
Poland
Spain
United Kingdom
United States
View All

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

 		Hypercholesterolemia Phase 3 United States

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

 		Rotator Cuff Tendinopathy Phase 3 United States
Italy
Thailand
Spain
Poland
Hungary
China
Denmark
Greece
View All

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

 		IC-MPGN Phase 3 United States
Turkey
Spain
Brazil
Germany
Switzerland
United Kingdom
Japan
Israel
Italy
France
Poland
Czech Republic
View All

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase 2 Kenya
Côte D'Ivoire
Uganda
Ghana
View All

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

 		Primary Prevention of Atherosclerotic Cardiovascular Disease Phase 3

The Belgian REAL (BE.REAL) Registry

 		Atherosclerotic Cardiovascular Disease Belgium

Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy

 		Rotator Cuff Tendinopathy Phase 3 United States
Turkey
Slovakia
Czech Republic
Argentina
France
Malaysia
Portugal
United Kingdom
Canada
Chile
Bulgaria
Denmark
View All

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

 		Non-Small-Cell Lung Carcinoma Korea, Republic of

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

 		Breast Cancer France